Potential asthma management via yeast
                Perinatal administration of Saccharomyces cerevisiae UFMG A-905 prevents asthma development in the offspring of mice.
                                                    
                                    
                             
         
        
            
            We explored how perinatal administration of Saccharomyces cerevisiae UFMG A-905 could help prevent asthma in mouse offspring. This study involved various groups of mice receiving the yeast at different stages: before conception, during pregnancy, or only during lactation. 
        Our results showed that those exposed to S. cerevisiae exhibited significantly less airway hyperresponsiveness and lower levels of certain inflammatory markers compared to those that didn’t receive the treatment. Notably, the greatest protection occurred when the yeast was given during lactation. 
        Overall, it seems that S. cerevisiae UFMG A-905 shows promise in the management of asthma, especially when administered early in the offspring's development.                    
         
         
    
                    
        
            
            
            
            Allergy relief achieved                 
                    
Most Useful Review
                                                    
                        71 people found this helpful
                    
                             
         
        
            Making a difference. I started taking these pills after learning about the clinical research on this compound. As a former cancer patient, the reported anti-tumour and immune stimulation seemed beneficial. I didn't expect immediate results, but after a month on this supplement, my low-level allergies have vanished. This was an unexpected and welcome benefit. I will continue to buy this brand in the future.